Amin Yehya, MD
Advanced Heart Failure and Transplant Cardiology · Norfolk, VANPI 1376720946
Payments from drug & device makers
Across 588 payments — averaging $1093.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$186K
- Merck$108K
- Akcea Therapeutics, Inc.$93K
- Scpharmaceuticals Inc.$54K
- Nuwellis, Inc.$45K
- AstraZeneca$32K
- plus $124K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 95 | $186,428 |
| Merck | 83 | $107,688 |
| Akcea Therapeutics, Inc. | 70 | $93,144 |
| Scpharmaceuticals Inc. | 43 | $53,786 |
| Nuwellis, Inc. | 27 | $45,090 |
| AstraZeneca | 43 | $32,207 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 37 | $26,665 |
| Kestra Medical Technology Services, Inc. | 6 | $21,634 |
| Alnylam Pharmaceuticals Inc. | 8 | $17,689 |
| Novo Nordisk | 11 | $17,052 |
| Cvrx, Inc. | 51 | $14,741 |
| Bridgebio Pharma, Inc. | 12 | $10,598 |
| Novartis | 1 | $7,636 |
| Abbott | 68 | $4,667 |
| Medtronic(2 entities) | 19 | $2,148 |
| Amgen | 3 | $530 |
| Boehringer Ingelheim | 2 | $238 |
| Impulse Dynamics (USA) Inc. | 2 | $231 |
| Endotronix, Inc. | 1 | $225 |
| Vifor Pharma, Inc. | 1 | $127 |
| Lilly USA, LLC | 1 | $95 |
| Abiomed | 1 | $41 |
| Cardiva Medical, Inc. | 1 | $30 |
| Phadia US Inc. | 1 | $20 |
| Pfizer | 1 | $15 |
How this compares
$642,726 in reported general payments places this provider in the 90th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.
See all advanced heart failure and transplant cardiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Norfolk
- Raymond BenzaNorfolk$764K
- Manjula AnanthramNorfolk$532K
- Zackary TushakNorfolk$92K
- Robert BernsteinNorfolk$27K
- John HerreChesapeake$672K
- Palak ShahFalls Church$662K
- Keyur ShahRichmond,$573K
- Mirnela BykuCharlottesville$414K
- Jamie KennedyFalls Church$354K
- Wayne OldChesapeake$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.